VV-Hemorphin-5 Peptide

Protein Family: Receptors and Channels

Pathway and Disease: Signaling Molecules and Interaction

Alternate Names: Hemorphin-5; VV-hemorphin-5; Valorphin; Hemoglobin subunit beta; beta-globin; hemoglobin beta chain

Accession No.: P68871

Description:
Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. VV-hemorphins and LVV-hemorphins preferentially interact with delta and kappa receptors, therefore playing the roles of endogenous opiate peptide in vivo. VV-hemorphin-5 has been shown to have antitumor effect both in vitro and in vivo.

Format:
Each vial contains 1 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt.

MW: 892.0 g/mol

Sequence:
H-Val-Val-Tyr-Pro-Trp-Thr-Gln-OH or H-VVYPWTQ-OH

Composition:
C44H61N9O11

Purity:
> 95% by HPLC

Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.

Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.